Pengendalian Bau Berbasis Metronidazole pada Pasien Luka Kanker di Rumah Sakit
A Scooping Review
DOI:
https://doi.org/10.31004/anthor.v5i4.991Keywords:
Luka Kanker, Bau, MetronidazolAbstract
Latar belakang: Luka kanker merupakan salah satu komplikasi dari kanker stadium lanjut. Salah satu masalah dari luka ganas adalah bau busuk yang sangat menganggu. Beberapa terapi yang dapat digunakan untuk mengendalikan bau adalah poliheksametilen binguanida (PHMB), teh hijau, madu manuka, nanopartikel perak nanokristalin dan metronidazole. Scooping review ini mengevaluasi penggunaan metronidazole dalam mengendalikan bau pada pasien luka kanker di rumah sakit. Metode: Scooping review menggunakan kerangka oleh Arkey and O'Malley. Untuk literature penelitian dilakukan pada enam database, yaitu pubmed, science direct, cohcran libray, garuda, willey, secondary research dari 2015-2025. Kriteria inklusi berfokus penggunaan metronidazole pada pasien yang mengalami bau busuk pada kanker di rumah sakit. Hasil: Dari artikel 469 yang diperiksa, hanya 8 artikel yang memenuhi kriteria dan telah dimasukkan dalam review ini. Hasil review menunjukkan bahwa metronidazole mampu mengendalikan bau busuk pada luka kanker, dalam berbagai sediaan; metronidazole bubuk, gel metronidazole 0,75%, kombinasi metronidazole dan zink oksida, larutanb metronidazole 0.8%, dan metronidazole oral. Kesimpulan: Scooping review ini memberikan pemahamann yang komprehensif tentang sediaan metronidazole terbukti mengendalikan bau busuk pada luka kanker. Diharapkan pemberian terapi metronidazole dapat diintegrasikan dalam protokol pengelolaan bau di rumah sakit.
References
Akhmetova, A., Saliev, T., Allan, I. U., Illsley, M. J., Nurgozhin, T., & Mikhalovsky, S. (2016). A comprehensive review of topical odor-controlling treatment options for chronic wounds. Journal of Wound, Ostomy and Continence Nursing, 43(6), 598–609. https://doi.org/10.1097/WON.0000000000000273
Asrizal, Wirda, & Wahyuni, S. (2022). Buku ajar manajemen perawatan luka: Teori dan aplikasi. Deepublish.
Cornish, L. (2019). Holistic management of malignant wounds in palliative patients. British Journal of Community Nursing, 24(Suppl. 9), S19–S23. https://doi.org/10.12968/bjcn.2019.24.Sup9.S19
Febrianti, N., Tahir, T., & Yusuf, S. (2019). Studi literatur peran epidermal growth factor dalam proses penyembuhan luka. Jurnal Keperawatan Muhammadiyah, 4(1), 7–13. https://doi.org/10.30651/jkm.v4i1.1852
Furka, A., Simkó, C., Kostyál, L., Szabó, I., Valikovics, A., Fekete, G., Tornyi, I., Oross, E., & Révész, J. (2022). Treatment algorithm for cancerous wounds: A systematic review. Cancers, 14(5), 1–12. https://doi.org/10.3390/cancers14051203
George, R., Prasoona, T. S., Kandasamy, R., Cherian, R., Celine, T., Jeba, J., Murali, S., & Mathew, D. (2017). Improving malodour management in advanced cancer: A 10-year retrospective study of topical, oral and maintenance metronidazole. BMJ Supportive & Palliative Care, 7(3), 286–291. https://doi.org/10.1136/bmjspcare-2016-001166
Gethin, G., Grocott, P., Probst, S., & Clarke, E. (2014). Current practice in the management of wound odour: An international survey. International Journal of Nursing Studies, 51(6), 865–874. https://doi.org/10.1016/j.ijnurstu.2013.10.013
Haddad, R., Taha, H., & Fawaree, F. (2022). The effectiveness of topical metronidazole management for malignant fungating wound odor: Nursing perspective. Cancer Studies and Therapeutics, 7(1), 1–4. https://doi.org/10.31038/cst.2022712
Arksey, H., & O'Malley, L. (2005). Scoping studies: Towards a methodological framework. International Journal of Social Research Methodology, 8(1), 19–32. https://doi.org/10.1080/1364557032000119616
Hu, J. K., Ligtenberg, K. G., Leventhal, J., & Bunick, C. G. (2020). Successful management of malodor from fungating tumors using crushed metronidazole tablets. JAAD Case Reports, 6(1), 26–29. https://doi.org/10.1016/j.jdcr.2019.10.025
Lian, S. B., Xu, Y., Goh, S. L., & Aw, F. C. (2014). Comparing the effectiveness of green tea versus topical metronidazole powder in malodorous control of fungating malignant wounds in a controlled randomised study. Proceedings of Singapore Healthcare, 23(1), 3–12. https://doi.org/10.1177/201010581402300102
Lofmark, S., Edlund, C., & Nord, C. E. (2010). Metronidazole is still the drug of choice for treatment of anaerobic infections. Clinical Infectious Diseases, 50(Suppl. 1), S16–S23. https://doi.org/10.1086/647939
Merz, T., Klein, C., Uebach, B., Kern, M., Ostgathe, C., & Bükki, J. (2011). Fungating wounds: Multidimensional challenge in palliative care. Breast Care, 6(1), 21–24. https://doi.org/10.1159/000324923
Ousey, K. (2018). The role of topical metronidazole in management of infected wounds. Wounds UK, 14(5), 105–109.
Peng, L., & Dai, Y. (2019). Effect of metronidazole combined with autolytic debridement for the management of malignant wound malodor. Journal of International Medical Research, 48(4), 0300060519889746. https://doi.org/10.1177/0300060519889746
Ramasubbu, D. A., Smith, V., Hayden, F., & Cronin, P. (2017). Systemic antibiotics for treating malignant wounds. Cochrane Database of Systematic Reviews, 2017(8). https://doi.org/10.1002/14651858.CD011609.pub2
Starace, M., Carpanese, M. A., Pampaloni, F., Dika, E., Pileri, A., Rubino, D., Alessandrini, A., Zamagni, C., Baraldi, C., Misciali, C., Patrizi, A., Bianchi, T., Apalla, Z., & Piraccini, B. M. (2022). Management of malignant cutaneous wounds in oncologic patients. Supportive Care in Cancer, 30(9), 7615–7623. https://doi.org/10.1007/s00520-022-07194-0
Tilley, C., Lipson, J., & Ramos, M. (2016). Palliative wound care for malignant fungating wounds: Holistic considerations at end-of-life. Nursing Clinics of North America, 51(3), 513–531. https://doi.org/10.1016/j.cnur.2016.05.006
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., Hempel, S., Akl, E. A., Chang, C., McGowan, J., Stewart, L., Hartling, L., Aldcroft, A., Wilson, M. G., Garritty, C., ... Straus, S. E. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169(7), 467–473. https://doi.org/10.7326/M18-0850
Vardhan, M., Flaminio, Z., Sapru, S., Tilley, C. P., Fu, M. R., Comfort, C., Li, X., & Saxena, D. (2019). The microbiome, malignant fungating wounds, and palliative care. Frontiers in Cellular and Infection Microbiology, 9, Article 373. https://doi.org/10.3389/fcimb.2019.00373
Wahidi, K. R. (2018). Efektivitas perawatan malodor luka kanker menggunakan formula topikal inovatif (FTI) dalam upaya meningkatkan kualitas hidup pasien kanker payudara. Hospitalia, 1, 118–133.
Watanabe, K., Shimo, A., Tsugawa, K., Tokuda, Y., Yamauchi, H., Miyai, E., Takemura, K., Ikoma, A., & Nakamura, S. (2016). Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75% gel (GK567): A multicenter, open-label, phase III study (RDT.07.SRE.27013). Supportive Care in Cancer, 24(6), 2583–2590. https://doi.org/10.1007/s00520-015-3067-0
Winardi, A., & Irwan, A. M. (2019). Topical treatment for controlling malignant wound odour. 20(2).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Nirmasari, Zulfiah, Ulfa
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
